Cardiac Rhythm Management (CRM) Devices

Cardiac Rhythm Management (CRM) Devices

Global Cardiac Rhythm Management (CRM) Devices Market to Reach US$23.9 Billion by 2030

The global market for Cardiac Rhythm Management (CRM) Devices estimated at US$18.5 Billion in the year 2023, is expected to reach US$23.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.6% CAGR

The Cardiac Rhythm Management (CRM) Devices market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Cardiac Rhythm Management (CRM) Devices Market - Key Trends and Drivers Summarized

Cardiac Rhythm Management (CRM) devices are crucial in the medical field for diagnosing and treating irregular heart rhythms and other related cardiac conditions. These devices include a diverse array of products such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, all designed to ensure proper heart function. Pacemakers are primarily used to manage bradycardia by sending electrical impulses to stimulate a consistent heartbeat. ICDs, on the other hand, continuously monitor heart rhythms and deliver life-saving shocks to restore normal rhythm during episodes of severe arrhythmias or sudden cardiac arrest. CRT devices are particularly beneficial for patients with heart failure, as they coordinate the contractions of the heart`s ventricles, improving the efficiency of each heartbeat. The CRM device landscape has seen substantial technological advancements, such as the development of leadless pacemakers, which eliminate the need for leads (wires) and thereby reduce infection risks and procedural complications. Additionally, MRI-compatible CRM devices have emerged, allowing patients with these implants to safely undergo magnetic resonance imaging, which was previously contraindicated.

The market for CRM devices is experiencing significant growth driven by the rising prevalence of cardiovascular diseases and the increasing adoption of advanced diagnostic and therapeutic technologies. Cardiovascular diseases remain one of the leading causes of mortality worldwide, affecting millions of people and creating a substantial demand for effective management solutions. The aging global population, which is more susceptible to cardiac conditions, further drives the need for CRM devices. Moreover, the integration of remote monitoring systems in CRM devices has revolutionized patient care by enabling continuous, real-time monitoring of heart rhythms, thereby facilitating timely medical interventions. These remote systems not only improve patient outcomes by providing early detection of potential issues but also reduce the need for frequent hospital visits and readmissions, ultimately lowering healthcare costs. Healthcare providers are increasingly adopting these advanced CRM devices to enhance the quality of care. Additionally, favorable reimbursement policies and growing healthcare expenditure in both developed and emerging markets are bolstering the adoption of CRM devices across various healthcare settings.

The growth in the CRM devices market is driven by several factors, including technological advancements, the rising incidence of cardiovascular diseases, and the growing preference for minimally invasive procedures. Technological innovations, such as wireless CRM devices and the integration of artificial intelligence, have significantly enhanced the functionality and patient-friendliness of these devices, leading to increased adoption. The development of leadless pacemakers and MRI-compatible devices has expanded the addressable market by offering safer and more versatile options for patients. The increasing prevalence of cardiovascular diseases, coupled with an aging population, has heightened the demand for CRM devices as effective management tools. Moreover, the shift towards outpatient procedures and home-based care models has driven the demand for portable and remotely monitored CRM devices. Regulatory approvals and standards have also played a crucial role in propelling market adoption, ensuring the safety and efficacy of these devices. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising investments in cardiac care facilities have generated new growth opportunities, making advanced CRM technologies more accessible to a broader patient population. These factors collectively underscore the robust growth trajectory of the CRM devices market, reflecting the increasing need for innovative and effective cardiac care solutions.

Select Competitors (Total 34 Featured) -

• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Koninklijke Philips NV
• LivaNova PLC
• Medtronic, Inc.
• Physio-Control, Inc.
• Schiller AG
• ZOLL Medical Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.